Drug profile · INN
rilzabrutinib
WAYRILZ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
rilzabrutinib (WAYRILZ) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN rilzabrutinib
Brand WAYRILZ
Route ORAL
Formulation TABLET
ATC code Not yet assigned
Frequently asked questions
What is rilzabrutinib?
rilzabrutinib (WAYRILZ) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for rilzabrutinib?
WAYRILZ is a marketed brand name for rilzabrutinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of rilzabrutinib?
rilzabrutinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.